We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is BrightSpring Health Services, Inc. (BTSG) Outperforming Other Medical Stocks This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is BrightSpring Health Services, Inc. (BTSG - Free Report) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
BrightSpring Health Services, Inc. is one of 986 companies in the Medical group. The Medical group currently sits at #8 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. BrightSpring Health Services, Inc. is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for BTSG's full-year earnings has moved 23.3% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Our latest available data shows that BTSG has returned about 17.8% since the start of the calendar year. Meanwhile, the Medical sector has returned an average of -4.6% on a year-to-date basis. This means that BrightSpring Health Services, Inc. is outperforming the sector as a whole this year.
Another stock in the Medical sector, Incyte (INCY - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 0.2%.
Over the past three months, Incyte's consensus EPS estimate for the current year has increased 2.5%. The stock currently has a Zacks Rank #2 (Buy).
Breaking things down more, BrightSpring Health Services, Inc. is a member of the Medical Services industry, which includes 58 individual companies and currently sits at #91 in the Zacks Industry Rank. On average, stocks in this group have lost 5.3% this year, meaning that BTSG is performing better in terms of year-to-date returns.
In contrast, Incyte falls under the Medical - Biomedical and Genetics industry. Currently, this industry has 494 stocks and is ranked #83. Since the beginning of the year, the industry has moved -0.6%.
Investors interested in the Medical sector may want to keep a close eye on BrightSpring Health Services, Inc. and Incyte as they attempt to continue their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is BrightSpring Health Services, Inc. (BTSG) Outperforming Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is BrightSpring Health Services, Inc. (BTSG - Free Report) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
BrightSpring Health Services, Inc. is one of 986 companies in the Medical group. The Medical group currently sits at #8 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. BrightSpring Health Services, Inc. is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for BTSG's full-year earnings has moved 23.3% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Our latest available data shows that BTSG has returned about 17.8% since the start of the calendar year. Meanwhile, the Medical sector has returned an average of -4.6% on a year-to-date basis. This means that BrightSpring Health Services, Inc. is outperforming the sector as a whole this year.
Another stock in the Medical sector, Incyte (INCY - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 0.2%.
Over the past three months, Incyte's consensus EPS estimate for the current year has increased 2.5%. The stock currently has a Zacks Rank #2 (Buy).
Breaking things down more, BrightSpring Health Services, Inc. is a member of the Medical Services industry, which includes 58 individual companies and currently sits at #91 in the Zacks Industry Rank. On average, stocks in this group have lost 5.3% this year, meaning that BTSG is performing better in terms of year-to-date returns.
In contrast, Incyte falls under the Medical - Biomedical and Genetics industry. Currently, this industry has 494 stocks and is ranked #83. Since the beginning of the year, the industry has moved -0.6%.
Investors interested in the Medical sector may want to keep a close eye on BrightSpring Health Services, Inc. and Incyte as they attempt to continue their solid performance.